Trials / Conditions / Japanese Encephalitis Virus Disease
Japanese Encephalitis Virus Disease
3 registered clinical trials studyying Japanese Encephalitis Virus Disease — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonuc NCT06680128 | SK Bioscience Co., Ltd. | Phase 1 / Phase 2 |
| Unknown | Purified Inactivated Japanese Encephalitis Vaccine NCT04223037 | Chinese Academy of Medical Sciences | Phase 3 |
| Completed | Study of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV™) Compared to CD.JEVAX™ in Tod NCT01396512 | Sanofi Pasteur, a Sanofi Company | Phase 3 |